| Dynamics of chronic myeloid leukaemia F Michor, TP Hughes, Y Iwasa, S Branford, NP Shah, CL Sawyers, ... Nature 435 (7046), 1267, 2005 | 830 | 2005 |
| Clonal evolution in breast cancer revealed by single nucleus genome sequencing Y Wang, J Waters, ML Leung, A Unruh, W Roh, X Shi, K Chen, P Scheet, ... Nature 512 (7513), 155, 2014 | 671 | 2014 |
| Dynamics of cancer progression F Michor, Y Iwasa, MA Nowak Nature reviews cancer 4 (3), 197, 2004 | 450 | 2004 |
| Optimization of dosing for EGFR-mutant non–small cell lung cancer with evolutionary cancer modeling J Chmielecki, J Foo, GR Oxnard, K Hutchinson, K Ohashi, R Somwar, ... Science translational medicine 3 (90), 90ra59-90ra59, 2011 | 446 | 2011 |
| Epidermal growth factor receptor tyrosine kinase inhibitor–resistant disease K Ohashi, YE Maruvka, F Michor, W Pao Journal of Clinical Oncology 31 (8), 1070, 2013 | 384 | 2013 |
| Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity A Marusyk, DP Tabassum, PM Altrock, V Almendro, F Michor, K Polyak Nature 514 (7520), 54, 2014 | 377 | 2014 |
| A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia A Klinakis, C Lobry, O Abdel-Wahab, P Oh, H Haeno, S Buonamici, ... Nature 473 (7346), 230, 2011 | 333 | 2011 |
| Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies H Haeno, M Gonen, MB Davis, JM Herman, CA Iacobuzio-Donahue, ... Cell 148 (1-2), 362-375, 2012 | 306 | 2012 |
| Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype SY Park, M Gönen, HJ Kim, F Michor, K Polyak The Journal of clinical investigation 120 (2), 636-644, 2010 | 306 | 2010 |
| The mathematics of cancer: integrating quantitative models PM Altrock, LL Liu, F Michor Nature Reviews Cancer 15 (12), 730-745, 2015 | 279 | 2015 |
| Synergy and discounting of cooperation in social dilemmas C Hauert, F Michor, MA Nowak, M Doebeli Journal of theoretical biology 239 (2), 195-202, 2006 | 264 | 2006 |
| Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response NA Jones, X Wei, DR Flower, ML Wong, F Michor, MS Saag, BH Hahn, ... Journal of Experimental Medicine 200 (10), 1243-1256, 2004 | 258 | 2004 |
| Successful therapy must eradicate cancer stem cells D Dingli, F Michor Stem cells 24 (12), 2603-2610, 2006 | 241 | 2006 |
| Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma T Ozawa, M Riester, YK Cheng, JT Huse, M Squatrito, K Helmy, N Charles, ... Cancer cell 26 (2), 288-300, 2014 | 235 | 2014 |
| Studying clonal dynamics in response to cancer therapy using high-complexity barcoding CB Hyo-eun, DA Ruddy, VK Radhakrishna, JX Caushi, R Zhao, MM Hims, ... Nature medicine 21 (5), 440, 2015 | 220 | 2015 |
| Stochastic tunnels in evolutionary dynamics Y Iwasa, F Michor, MA Nowak Genetics 166 (3), 1571-1579, 2004 | 219 | 2004 |
| Polyploidy can drive rapid adaptation in yeast AM Selmecki, YE Maruvka, PA Richmond, M Guillet, N Shoresh, ... Nature 519 (7543), 349, 2015 | 215 | 2015 |
| Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity V Almendro, YK Cheng, A Randles, S Itzkovitz, A Marusyk, E Ametller, ... Cell reports 6 (3), 514-527, 2014 | 207 | 2014 |
| Evolution of resistance during clonal expansion Y Iwasa, MA Nowak, F Michor Genetics 172 (4), 2557-2566, 2006 | 202 | 2006 |
| Can chromosomal instability initiate tumorigenesis? F Michor, Y Iwasa, B Vogelstein, C Lengauer, MA Nowak Seminars in cancer biology 15 (1), 43-49, 2005 | 196 | 2005 |
